AbbVie Biotherapeutics Inc.;Dana-Farber Cancer Institute, Inc.
发明人:
申请号：
EP16169025.0
公开号：
EP3115049A1
申请日:
2007.08.07
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
Composition suitable for treating multiple myeloma in subject, comprising a therapeutically effective amount of HuLuc63, a therapeutically effective amount of lenalidomide and/or bortezomib, and a pharmaceutically acceptable carrier, wherein said composition is capable of being administered in a single or multiple dose regimen.
